Tudor Investment Corp
CABA icon

Tudor Investment Corp’s Cabaletta Bio CABA Stock Holding History

Tudor Investment Corp’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,604
Closed -$46.8K – 3092
2024
Q4 		$46.8K Buy
+20,604
New +$72.3K ﹤0.01% 2933
2024
Q2 		– Sell
-21,314
Closed -$364K – 2347
2024
Q1 		$364K Buy
+21,314
New +$457K ﹤0.01% 1784

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Tudor Investment Corp's CABA Position: Q1 2025 in Review

Tudor Investment Corp sold out of Cabaletta Bio (CABA) in Q1 2025, closing a stake of 20,604 shares — an estimated $46.8K sold.

Tudor Investment Corp first reported a position in CABA in Q1 2024 and held it in 2 quarters. The position peaked at $364K in Q1 2024. 92 funds tracked by Wall St. Rank hold CABA as of Q1 2025.

  • Tudor Investment Corp reported no remaining Cabaletta Bio position as of Q1 2025 after selling out during the quarter.
  • Tudor Investment Corp sold 20,604 Cabaletta Bio shares in Q1 2025, an estimated $46.8K.
  • Tudor Investment Corp first reported a position in Cabaletta Bio in Q1 2024 and held it in 2 quarters.
  • Tudor Investment Corp's Cabaletta Bio position peaked at $364K in Q1 2024.
  • 92 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2025.

Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.